Marshall Wace, LLP Inmune Bio, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 26,825 shares of INMB stock, worth $216,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,825Holding current value
$216,477% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding INMB
# of Institutions
57Shares Held
2.88MCall Options Held
44.6KPut Options Held
3.5K-
Vanguard Group Inc Valley Forge, PA541KShares$4.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY240KShares$1.94 Million0.0% of portfolio
-
Mai Capital Management181KShares$1.46 Million0.02% of portfolio
-
Rhenman & Partners Asset Management Ab Stockholm, V7178KShares$1.44 Million0.2% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$1.38 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $145M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...